Search results
The long-term health risks of ketamine, including bladder issues
Yahoo Life UK· 3 days agoWith there an increase in 'ketamine bladder' among young people, what other problems can excessive...
As ketamine therapy booms, industry insiders worry about patient safety
Market Watch· 7 days agoThe incident raises broader questions about at-home ketamine therapy, the doctors wrote. Guidelines...
...) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for ...
FOX 5 San Diego· 2 days agoNRX-101 is first oral antidepressant to show 33% advantage in sustained remission in suicidality (not statistically significant at this sample size) and 75% advantage in relief from Akathisia ...
Utah woman finds relief from depression with ketamine therapy
KSL Salt Lake City· 3 days agoThis story is sponsored by Anew Therapy. What if your depression could improve radically in a matter...
At least 17 people died in Florida after medics injected sedatives during encounters with police
ABC Action News Tampa Bay· 6 days agoAt least 17 people died in Florida over a decade following a physical encounter with police during which medical personnel also injected them with a powerful sedative, an investigation led by ...
Psychedelic Tx: What Meaningful Informed Consent Looks Like
Medscape· 2 days agoThe US Food and Drug Administration has designated psilocybin and 3,4-methylenedioxymethamphetamine...
Can Esketamine Prevent Postpartum Depression?
Medscape· 6 days agoData suggest that a low dose of esketamine immediately after childbirth reduces major depressive episodes in women with prenatal depression.
DEA’s Psychedelic-Outlawing Effort Attacked by Private Industry | The Legal Intelligencer
Law.com· 3 days agoDespite the U.S. Food and Drug Administration’s approval of depression treatment drug Esketamine and...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoThe first phase of the collaboration comprises an in-depth information exchange on the COMP360 psilocybin treatment delivery model.
NRX-101 shows promise in bipolar depression trial By Investing.com
Investing.com· 2 days agoNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) has reported findings from a clinical trial suggesting that...